Related references
Note: Only part of the references are listed.The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols
Rachael F. Grace et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia
Lewis B. Silverman et al.
BLOOD (2010)
The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers
Jennifer L. McNeer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Asparaginase-related venous thrombosis in UKALL 2003-re-exposure to asparaginase is feasible and safe
Amrana Qureshi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
A Randomized, Controlled, Double-Blind, Pilot Study of Milk Thistle for the Treatment of Hepatotoxicity in Childhood Acute Lymphoblastic Leukemia (ALL)
Elena J. Ladas et al.
CANCER (2010)
Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: A retrospective study
Luigi Gugliotta et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia
Elizabeth A. Raetz et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2010)
Silent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia
Marion Strullu et al.
LEUKEMIA & LYMPHOMA (2010)
Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment
Ulrike Nowak-Goettl et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2009)
The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase
Lesleigh S. Abbott et al.
BLOOD (2009)
Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen
John M. Storring et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Comparison of Native E. coli and PEG Asparaginase Pharmacokinetics and Pharmacodynamics in Pediatric Acute Lymphoblastic Leukemia
J. C. Panetta et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Young Adults With Acute Lymphoblastic Leukemia Have an Excellent Outcome With Chemotherapy Alone and Benefit From Intensive Postinduction Treatment: A Report From the Children's Oncology Group
James B. Nachman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
Francoise Huguet et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Hyperammonemic Encephalopathy After Induction Chemotherapy for Acute Lymphoblastic Leukemia
Tang-Her Jaing et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Dexamethasone induces a heat-stress response that ameliorates the conformational consequences on antithrombin of l-asparaginase treatment
D. Hernandez-Espinosa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Treating Childhood Leukemia without Cranial Irradiation
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prevalence of Transient Hyperglycemia During Induction Chemotherapy for Pediatric Acute Lymphoblastic Leukemia
Stefanie R. Lowas et al.
PEDIATRIC BLOOD & CANCER (2009)
Clinical Course and Outcome in Children With Acute Lymphoblastic Leukemia and Asparaginase-Associated Pancreatitis
Susan L. Kearney et al.
PEDIATRIC BLOOD & CANCER (2009)
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock et al.
BLOOD (2008)
Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic
Akira Morimoto et al.
CANCER (2008)
Retherapy using L-asparaginase with octreotide in a patient recovering from L-asparagmase-induced pancreatitis
Mitsuyoshi Suzuki et al.
EXPERIMENTAL HEMATOLOGY (2008)
Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study
Mathilde Hunault-Berger et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia
Lei Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia
Bernhard Meister et al.
PEDIATRIC BLOOD & CANCER (2008)
New agents for the treatment of patients with acute lymphoblastic leukemia
Daniel J. DeAngelo et al.
Current Hematologic Malignancy Reports (2008)
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Nita L. Seibel et al.
BLOOD (2008)
Predicting asparaginase-associated pancreatitis
Holly M. Knoderer et al.
PEDIATRIC BLOOD & CANCER (2007)
Thrombosis and acute lymphoblastic leukaemia
Jeanette H. Payne et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
Intensified PEG-L-asparaginase and anti metabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia - A report from the Children's Oncology Group
Wanda L. Salzer et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2007)
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511
Meir Wetzler et al.
BLOOD (2007)
Cerebral sinovenous thrombosis in children
Tali Jonas Kimchi et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2007)
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols
Elly Barry et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials
Ramya Ramanujachar et al.
PEDIATRIC BLOOD & CANCER (2007)
The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia
Beata Zalewska-Szewczyk et al.
LEUKEMIA & LYMPHOMA (2007)
Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis
V. Caruso et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
FDA drug approval summary: Pegaspargase (Oncaspar (R)) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)
Patricia Anne Dinndorf et al.
ONCOLOGIST (2007)
Adolescents with acute lymphoblastic leukaemia: Emerging from the shadow of paediatric and adult treatment Protocols
Ramya Ramanujachar et al.
PEDIATRIC BLOOD & CANCER (2006)
Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients
Vanesa Caruso et al.
BLOOD (2006)
L-Asparaginase-induced antithrombin type I deficiency -: Implications for conformational diseases
David Hernandez-Espinosa et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase
Michael Bodmer et al.
DIGESTION (2006)
Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations - The past, the present and recommendations for the future
VI Avramis et al.
CLINICAL PHARMACOKINETICS (2005)
L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage
PC Top et al.
PEDIATRIC BLOOD & CANCER (2005)
Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit
H Imaizumi et al.
PANCREAS (2004)
Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia
DS Hawkins et al.
CLINICAL CANCER RESEARCH (2004)
Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: Incidence, risk factors, and possible role of antithrombin
MA Elliott et al.
LEUKEMIA & LYMPHOMA (2004)
Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands
JM de Bont et al.
LEUKEMIA (2004)
Pegaspargase: a review of clinical studies
ML Graham
ADVANCED DRUG DELIVERY REVIEWS (2003)
Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia
M Kieslich et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols):: prednisone versus dexamethasone administration
U Nowak-Göttl et al.
BLOOD (2003)
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials
N Boissel et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase - Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) study
LG Mitchell
CANCER (2003)
Pegylated asparaginase in combination with high-dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study
O Rosen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Endocrine complications in pediatric patients with acute lymphoblastic leukemia
SC Howard et al.
BLOOD REVIEWS (2002)
L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia
B Rathi et al.
PEDIATRIC NEUROSURGERY (2002)
Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: A retrospective study by the JACLS
T Hongo et al.
PEDIATRICS INTERNATIONAL (2002)
Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies:: results of a randomized European Organisation for Research and Treatment of Cancer -: Children's Leukemia Group phase 3 trial
M Duval et al.
BLOOD (2002)
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia:: a Children's Cancer Group study
VI Avramis et al.
BLOOD (2002)
Drug monitoring of low-dose PEG-asparaginase (Oncaspar™) in children with relapsed acute lymphoblastic leukaemia
JPV Pinheiro et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
LB Silverman et al.
BLOOD (2001)
A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors
CW Taylor et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Pegylated asparaginase (Oncaspar™) in children with ALL:: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols
HJ Müller et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia
JE Bushman et al.
LEUKEMIA RESEARCH (2000)